Freelance writer for Contemporary OB/GYN
Whole genome sequencing of cell-free DNA for NIPT
May 5th 2021An analysis of a large cohort of patients who chose noninvasive prenatal testing (NIPT) as a screening method for fetal trisomy 21, 18, and 13 (T21, T18 and T13) and sex chromosome aneuploidies (SCA) concluded there were extremely high detection rates and exceptionally low false positive rates.
Read More
Contraception for women with cardiovascular disease
April 21st 2021Early and routine contraceptive counseling for all women of reproductive age with cardiovascular disease or cardiovascular risk factors is an essential component of comprehensive cardiovascular care, according to evidence-based recommendations of contraceptive options published in the Journal of the American College of Cardiology (JACC).
Read More
Radiofrequency ablation of uterine fibroids
April 15th 2021Transcervical fibroid ablation (TFA) to treat symptomatic uterine fibroids (UFs) is effective for a wide range of fibroid types and sizes, according to preliminary results of the first 160 women treated in the Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE registry).
Read More
Economic impact of coverage expansion for NIPT
April 15th 2021Expanding coverage for noninvasive prenatal testing (NIPT) through a performance-based, risk-sharing agreement (PBRSA) resulted in a significant increase in NIPT use, a significant decrease in conventional prenatal screening methods, and a negligible increase in per member per month (PMPM) cost at Harvard Pilgrim Health Care (HPHC) in New England.
Read More
Hominis surgical robot receives De Novo marketing authorization
March 23rd 2021The privately held medical device firm Memic Innovative Surgery Ltd. announced in early March that the Food and Drug Administration (FDA) has granted De Novo marketing authorization for its Hominis, a robot-assisted surgical platform for use in single site, natural orifice laparoscopic-assisted transvaginal benign gynecologic procedures, including benign hysterectomy.
Read More
Nextstellis combined oral contraceptive and endocrine markers
March 23rd 2021Limited changes occur in endocrine markers with the combined oral contraceptive Nextstellis (Mayne Pharma), according to a prospective study presented at the virtual annual meeting of the International Society for the Study of Women's Sexual Health (ISSWSH) in March.
Read More
Endometriosis impacts life on many levels
March 16th 2021Research indicates that women with endometriosis are prone to physical, psychosocial, social, and sexual disturbances and obstetrical complications, according to a literature search of the impact of endometriosis on various aspects of reproductive health in the Journal of Obstetrics and Gynaecology.
Read More
Clinical practice and research yields valuable data for management of uterine fibroids
March 15th 2021“New studies are showing significantly increased risks of cardiovascular disease, weight gain and mood disorders, even with bilateral ovarian conservation,” Elizabeth A. Stewart, MD, told Contemporary OB/GYN.
Read More
Evolving patient evaluation and therapies for uterine fibroids
March 15th 2021When it comes to diagnosing women with uterine fibroids (UFs), no single patient, fibroid or lived experience is the same, according to Sony Sukhbir Singh, MD, a professor of gynecology at the University of Ottawa and The Ottawa Hospital in Ontario, Canada.
Read More
Pelvic floor physiotherapy for endometriosis
March 10th 2021A prospective study in the journal Ultrasound in Obstetrics & Gynecology has found that women treated with pelvic floor physiotherapy showed a significant improvement in pelvic floor relaxation, superficial dyspareunia and chronic pelvic pain, in comparison to women who did not receive treatment.
Read More
Cost of cell-free DNA noninvasive testing for Down syndrome
March 9th 2021A public health screening program for Down syndrome in Quebec, Canada, found that cell-free DNA noninvasive prenatal testing (NIPT) could be implemented at the same cost as the current screening program, according to computer simulations.
Read More
Pathophysiology of uterine fibroids
March 8th 2021A better understanding of the pathophysiology of uterine fibroids (UFs) will enable healthcare providers to deliver high-quality informed care to their patients, according to Ayman Al-Hendy, MD, PhD, a professor of ob/gyn at Pritzker School of Medicine, University of Chicago.
Read More
Medicaid payments for immediate postpartum LARC
March 2nd 2021Since 2012, when South Carolina's Medicaid program became the first state Medicaid program to separate payment for the immediate postpartum placement of long-acting reversible contraception (LARC) from global maternity payment, a significantly greater number of mothers are using LARC, especially among adolescents.
Read More
Clinico-pathological assessment of post-cesarean section abdominal wall endometriosis
February 25th 2021A study of 30 women who had their post-cesarean section abdominal wall endometriomas (AWE) surgically removed found that the main symptom for detection and for surgery in two-thirds of cases was cyclic pain, whereas 13.3% of patients had no symptoms.
Read More
Expanding scope of noninvasive prenatal testing
February 23rd 2021“Our results can further inform the debate on the future uses of NIPT and future policy of its implementation,” said co-principal investigator Hazar Haidar, PhD, a lecturer in bioethics at Université du Québec à Montréal (UQAM), Montréal, Canada.
Read More